…up for ACGT’s e-newsletter. This monthly email delivers the latest news directly to your inbox. You’ll learn about the efforts of ACGT Research Fellows and ways you can help us…
…small. No matter if it’s traditional money or digital currency. The Alliance is excited to announce the acceptance of cryptocurrency donations for cancer research. We’ve set up a page on the ACGT website specifically…
…Cancer Gene Therapy funding, continues to be life-changing and life-saving for many people. As the focus shifts to solid tumors, Dr. June is again leading the medical community forward to…
…Cell Therapy for Relapsed or Refractory Lymphoma. ASH. Retrieved from: https://ash.confex.com/ash/2021/webprogram/Paper150431.html. Accessed: 12/29/2021. Blockade or deletion of IFNg reduces macrophage activation without compromising CAR-T function in hematologic malignancies. Blood Cancer…
…up for our monthly newsletter. Page sources BioNTech Presents Encouraging Phase 1/2 Follow-up Data for CAR-T Candidate BNT211 in Hard-To-Treat Solid Tumors at ESMO. Yahoo. Retrieved from: https://www.yahoo.com/now/biontech-presents-encouraging-phase-1-143000094.html. Accessed: 09/12/2022….
…for our monthly email newsletter and other communications. Page sources Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial. Biospace. Retrieved from: https://www.biospace.com/article/releases/anixa-biosciences-announces-treatment-of-first-patient-in-its-ovarian-cancer-car-t-clinical-trial/. Accessed: 09/09/2022….
…of solid tumors across multiple histologies,” said Conejo-Garcia, chair of Moffitt’s Department of Immunology. Page sources New target for CAR T cells in solid tumors. Science Daily. Retrieved from: https://www.sciencedaily.com/releases/2022/05/220504110424.htm….
…patients. Page sources With Approval for Axi-cel in Second-line on the Horizon, CAR T-Cell Therapy Poised to Enter New Phase. American Journal of Managed Care. Retrieved from: https://www.ajmc.com/view/with-approval-for-axi-cel-in-second-line-on-the-horizon-car-t-cell-therapy-poised-to-enter-new-phase. Accessed: 02/16/2022….
…GET UPDATES ABOUT ACGT RESEARCHERS Page sources Quantitative imaging of apoptosis following oncolytic virotherapy by magnetic resonance fingerprinting aided by deep learning. Nature Biomedical Engineering. Retrieved from: https://www.nature.com/articles/s41551-021-00809-7. Accessed: 01/14/2022….
…around commercial CAR T-cell dosing and didn’t know if higher doses would affect toxicity and compromise outcomes, or support enhanced anti-leukemia effect. This data has direct clinical applicability, as it…
…participants with glioblastoma, please visit the study’s page on clinicaltrials.gov. Page sources CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future. Frontiers. Retrieved: https://www.frontiersin.org/articles/10.3389/fimmu.2022.817296/full. Accessed: 08/01/2022….
…on the ACGT website. Page sources Key Statistics for Pancreatic Cancer. American Cancer Society. Retrieved from: https://www.cancer.org/cancer/types/pancreatic-cancer/about/key-statistics.html. Accessed: 09/29/2023. Pancreatic Cancer Prognosis. Johns Hopkins Medicine. Retrieved from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/pancreatic-cancer/pancreatic-cancer-prognosis. Accessed: 09/29/2023….
…tumor size (either partially or a complete disappearance). See a List of All Approved Cell and Gene Therapies Page sources FDA Approves First Gene Therapy to Treat Adults with Metastatic…
…questions and doing online research led the family to the Children’s Hospital of Philadelphia (CHOP) where she enrolled in the latest iteration of the CAR T-cell therapy clinical trial spearheaded…
…very unique and provides hope to patients,’” Kimberly said. On October 31, 2023, Austin reached an important milestone: 10 years cancer-free. That 10-year milestone is when scientists begin using a…
https://www.youtube.com/watch?v=mTOE8rgFqJA Executive Leadership The Alliance for Cancer Gene Therapy staff are dedicated to the success of our mission and goals. See our Executive Leadership Board of Directors These…
…this behavior that Dr. Brown intends to stop by equipping a patient’s own T cells to kill immune-suppressing macrophages in tumors. https://www.youtube.com/watch?v=UPPy4KwNUFM Dr. Brown’s creative strategy is rooted in the…
…either by itself or in a combination, and if your cancer is BRAF mutation-positive, a BRAF-inhibitor drug with or without a MEK inhibitor drug that has also stopped working. Tecelra…
…stuff,” says Tom, she shares hope for a future where fewer children face pain and uncertainty. The latest effort in the family’s desire to give back is their recent book,…
…metastasized cancer cells. We intend first to develop and test these agents in cultured cells. We will then test and optimize the ability of the virus to cure prostate cancer….
